Search results
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Morningstar· 6 days agoMedia Release Data from efti in combination with KEYTRUDA® in first line head and neck squamous cell carcinoma patients who do not express ...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 6 days agoHe also noted Moderna and Merck began testing their combination in squamous cell carcinoma, a form ...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 1 day agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Why Is Penny Stock HOOKIPA Pharma Trading Higher On Wednesday?
Benzinga via Yahoo Finance· 6 days agoIn January, Roche terminated the collaboration and licensing agreement for HOOKIPA’s HB-700 program...
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Morningstar· 6 days agoThe NDA is supported by results from JUPITER-02, a randomized, double-blind, placebo-controlled, multinational...
Stereotactic Radiosurgery to Treat 15-Plus Brain Metastases?
Medscape· 16 hours agoA large study supports the use of stereotactic radiosurgery in patients with 15 or more brain...
Fusion (FUSN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoFusion (FUSN) is expected to provide updates regarding the developmental program of its lead...
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Morningstar· 6 days agoGlobal licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential of novel radioenhancer NBTXR3Prolonged ...
Prairie Fare: Are you taking care of your skin?
The Bismarck Tribune· 6 days ago“I thought you were wearing white knee socks,” someone said.